Business Description
This fund puts nearly all of its money into American Depositary Receipts tied to Novo Nordisk A/S, a Danish pharmaceutical company, rather than buying the company's shares directly. It focuses entirely on a single holding, meaning investors are exposed to the performance of one company alone.
